Noushin Nabavi
Noushin Nabavi
University of British Columbia
Verified email at prostatecentre.com - Homepage
Title
Cited by
Cited by
Year
SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease
J Shin, M He, Y Liu, S Paredes, L Villanova, K Brown, X Qiu, N Nabavi, ...
Cell reports 5 (3), 654-665, 2013
1982013
Effects of microgravity on osteoclast bone resorption and osteoblast cytoskeletal organization and adhesion
N Nabavi, A Khandani, A Camirand, RE Harrison
Bone 49 (5), 965-974, 2011
1612011
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ...
Genome medicine 11 (1), 1-12, 2019
472019
Monocytes from patients with osteoarthritis display increased osteoclastogenesis and bone resorption: the In Vitro Osteoclast Differentiation in Arthritis study
M Durand, SV Komarova, A Bhargava, DP Trebec‐Reynolds, K Li, ...
Arthritis & Rheumatism 65 (1), 148-158, 2013
422013
The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis—the In Vitro Osteoclastá…
M Durand, G Boire, SV Komarova, SJ Dixon, SM Sims, RE Harrison, ...
Bone 48 (3), 588-596, 2011
372011
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
VR Ramnarine, M Alshalalfa, F Mo, N Nabavi, N Erho, M Takhar, ...
GigaScience 7 (6), giy050, 2018
332018
Targeting MCT 4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer
SYC Choi, SL Ettinger, D Lin, H Xue, X Ci, N Nabavi, RH Bell, F Mo, ...
Cancer medicine 7 (7), 3385-3392, 2018
312018
miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer
N Nabavi, NRN Saidy, E Venalainen, A Haegert, A Parolia, H Xue, ...
Scientific reports 7 (1), 1-10, 2017
292017
Lysosome dispersion in osteoblasts accommodates enhanced collagen production during differentiation
N Nabavi, Y Urukova, M Cardelli, JE Aubin, RE Harrison
Journal of Biological Chemistry 283 (28), 19678-19690, 2008
292008
Rab GTPase mediated procollagen trafficking in ascorbic acid stimulated osteoblasts
N Nabavi, S Pustylnik, RE Harrison
Public Library of Science 7 (9), e46265, 2012
262012
Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
N Nabavi, KL Bennewith, A Churg, Y Wang, CC Collins, L Mutti
Genes & cancer 7 (11-12), 340, 2016
242016
EB1 levels are elevated in ascorbic Acid (AA)-stimulated osteoblasts and mediate cell-cell adhesion-induced osteoblast differentiation
S Pustylnik, C Fiorino, N Nabavi, T Zappitelli, R da Silva, JE Aubin, ...
Journal of Biological Chemistry 288 (30), 22096-22110, 2013
242013
Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame
SM Kim, YQ Wang, N Nabavi, Y Liu, MA Correia
Drug metabolism reviews 48 (3), 405-433, 2016
222016
Optical waveguides formed by silver ion exchange in Schott SG11 glass for waveguide evanescent field fluorescence microscopy: evanescent images of HEK293 cells
A Hassanzadeh, M Nitsche, S Armstrong, N Nabavi, R Harrison, SJ Dixon, ...
Journal of biomedical optics 15 (3), 036018, 2010
192010
Progress in delivery of siRNA-based therapeutics employing nano-vehicles for treatment of prostate cancer
M Ashrafizadeh, K Hushmandi, E Rahmani Moghadam, V Zarrin, ...
Bioengineering 7 (3), 91, 2020
172020
Metabolic heterogeneity signature of primary treatment-na´ve prostate cancer
D Lin, SL Ettinger, S Qu, H Xue, N Nabavi, SYC Choi, RH Bell, F Mo, ...
Oncotarget 8 (16), 25928, 2017
162017
Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
S Mirzaei, AT Mohammadi, MH Gholami, F Hashemi, A Zarrabi, ...
Pharmacological research, 105575, 2021
102021
Long non-coding RNA in the doxorubicin resistance of cancer cells
S Ashrafizaveh, M Ashrafizadeh, A Zarrabi, K Husmandi, A Zabolian, ...
Cancer Letters, 2021
102021
Pre-clinical models for malignant mesothelioma research: From chemical-induced to patient-derived cancer xenografts
N Nabavi, J Wei, D Lin, CC Collins, PW Gout, Y Wang
Frontiers in genetics 9, 232, 2018
62018
Well-differentiated papillary mesothelioma of the peritoneum is genetically distinct from malignant mesothelioma
R Shrestha, N Nabavi, S Volik, S Anderson, A Haegert, B McConeghy, ...
Cancers 12 (6), 1568, 2020
52020
The system can't perform the operation now. Try again later.
Articles 1–20